Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04447703 · ClinicalTrials.gov registry record · NA
Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 346
- Enrollment target
NCT04447703 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 346 participants.
The verdict
NCT04447703, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 346 participants
- Enrollment target
Study Summary
This trial performs user testing of a mobile-friendly patient history collection and genetic education tool to improve healthcare providers' understanding of prostate cancer genetic testing. This trial also compares traditional genetic counseling versus a web-based genetic education (WBGE) tool to provide information about genetic testing to men with prostate cancer. The WBGE tool has educational modules on genetic counseling and testing, as well as a patient history collection tool to help providers learn which patients may carry genetic mutations and may be considered for genetic counseling and genetic testing. The purpose of this research is to use technology to deliver information on genetic testing for prostate cancer to patients to help them decide whether or not to receive genetic testing.
Interventions
- OTHER Survey Administration
- OTHER Interview
- OTHER Genetic Counseling
- GENETIC Genetic Testing
- OTHER Internet Based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2020-08-27 |
| Est. Completion | 2024-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04447703
The ClinicalTrials.gov registry entry for NCT04447703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 346 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Survey Administration is the first listed.
NCT04447703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04447703 about?
NCT04447703 is a clinical study titled "Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study". This trial performs user testing of a mobile-friendly patient history collection and genetic education tool to improve healthcare providers' understanding of prostate cancer genetic testing. This trial also compares traditional genetic counseling versus a web-based genetic education (WBGE) tool to p...
What is the current status of trial NCT04447703?
This trial is currently completed. It is a NA study. The enrollment target is 346 participants. The study started on 2020-08-27. Estimated completion is 2024-09-10.
What interventions are being tested in trial NCT04447703?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER), Genetic Counseling (OTHER), Genetic Testing (GENETIC), Internet Based Intervention (OTHER).
Who is sponsoring clinical trial NCT04447703?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.